These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8500889)

  • 1. Facilitation of complement-dependent killing of the Lyme disease spirochete, Borrelia burgdorferi, by specific immunoglobulin G Fab antibody fragments.
    Kochi SK; Johnson RC; Dalmasso AP
    Infect Immun; 1993 Jun; 61(6):2532-6. PubMed ID: 8500889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Complement-mediated killing of the Lyme disease spirochete Borrelia burgdorferi. Role of antibody in formation of an effective membrane attack complex.
    Kochi SK; Johnson RC; Dalmasso AP
    J Immunol; 1991 Jun; 146(11):3964-70. PubMed ID: 2033266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.
    Kochi SK; Johnson RC
    Infect Immun; 1988 Feb; 56(2):314-21. PubMed ID: 3276623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Complement-mediated killing of Borrelia burgdorferi by nonimmune sera from sika deer.
    Nelson DR; Rooney S; Miller NJ; Mather TN
    J Parasitol; 2000 Dec; 86(6):1232-8. PubMed ID: 11191897
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune evasion of Borrelia burgdorferi: insufficient killing of the pathogens by complement and antibody.
    Kraiczy P; Skerka C; Kirschfink M; Zipfel PF; Brade V
    Int J Med Microbiol; 2002 Jun; 291 Suppl 33():141-6. PubMed ID: 12141738
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Requirement of extracellular complement and immunoglobulin for intracellular killing of micro-organisms by human monocytes.
    Leijh PC; van den Barselaar MT; van Zwet TL; Daha MR; van Furth R
    J Clin Invest; 1979 Apr; 63(4):772-84. PubMed ID: 374424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A bactericidal antibody to Borrelia burgdorferi is directed against a variable region of the OspB protein.
    Sadziene A; Jonsson M; Bergström S; Bright RK; Kennedy RC; Barbour AG
    Infect Immun; 1994 May; 62(5):2037-45. PubMed ID: 7513309
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Classical Complement Pathway Is Required to Control
    Zhi H; Xie J; Skare JT
    Front Immunol; 2018; 9():959. PubMed ID: 29867944
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional heterogeneity in the antibodies produced to Borrelia burgdorferi.
    Benach JL
    Wien Klin Wochenschr; 1999 Dec; 111(22-23):985-9. PubMed ID: 10666815
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Borrelia burgdorferi antigens that are targeted by antibody-dependent, complement-mediated killing in the rhesus monkey.
    Aydintug MK; Gu Y; Philipp MT
    Infect Immun; 1994 Nov; 62(11):4929-37. PubMed ID: 7927774
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of the physiological requirements for the bactericidal effects of a monoclonal antibody to OspB of Borrelia burgdorferi by confocal microscopy.
    Escudero R; Halluska ML; Backenson PB; Coleman JL; Benach JL
    Infect Immun; 1997 May; 65(5):1908-15. PubMed ID: 9125579
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparative study of mammalian and reptilian alternative pathway of complement-mediated killing of the Lyme disease spirochete (Borrelia burgdorferi).
    Kuo MM; Lane RS; Giclas PC
    J Parasitol; 2000 Dec; 86(6):1223-8. PubMed ID: 11191895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complement evasion by the Lyme disease spirochete Borrelia burgdorferi grown in host-derived tissue co-cultures: role of fibronectin in complement-resistance.
    Güner ES
    Experientia; 1996 Apr; 52(4):364-72. PubMed ID: 8620942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Selection of an escape variant of Borrelia burgdorferi by use of bactericidal monoclonal antibodies to OspB.
    Coleman JL; Rogers RC; Benach JL
    Infect Immun; 1992 Aug; 60(8):3098-104. PubMed ID: 1639477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The complement-killing of Borrelia burgdorferi. Target antigens and sensitizing antibodies.
    Cacciapuoti B; Ciarrocchi S; Ciceroni L
    Zentralbl Bakteriol; 1998 Jul; 288(1):121-9. PubMed ID: 9728412
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-resistant strains of Borrelia burgdorferi evade complement-mediated killing by expressing a CD59-like complement inhibitory molecule.
    Pausa M; Pellis V; Cinco M; Giulianini PG; Presani G; Perticarari S; Murgia R; Tedesco F
    J Immunol; 2003 Mar; 170(6):3214-22. PubMed ID: 12626580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro inhibition of Borrelia burgdorferi growth by antibodies.
    Sadziene A; Thompson PA; Barbour AG
    J Infect Dis; 1993 Jan; 167(1):165-72. PubMed ID: 8418163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complement-mediated in vitro bactericidal activity of monoclonal antibodies reactive with outer-surface-protein OspB of Borrelia burgdorferi.
    Cevenini R; Sambri V; Massaria F; La Placa M; Brocchi E; De Simone F
    FEMS Microbiol Lett; 1992 Jan; 69(2):147-52. PubMed ID: 1537543
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.